Work

Supplementary Data from A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple Myeloma

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Tables and Figure

DOI: 10.1158/1078-0432.22471611

Authors: James R. Berenson, Jennifer To, Tanya M. Spektor, Daisy Martinez, Carley Turner, Armando Sanchez, Matthew Ghermezi, Benjamin M. Eades, Regina A. Swift, Gary Schwartz, Shahrooz Eshaghian, Laura Stampleman, Robert A. Moss, Stephen Lim, Robert Vescio

Institutions: Oncotherapeutics (United States), Institute for Myeloma & Bone Cancer Research, Cedars-Sinai Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361934838

Cites:

Cited by:

Related to: 10